drug_discovery
Tech Blog: New Drug Treatment For Ewing’s Sarcoma
Tech Launch AZ

Funded by the American Cancer Society and the National Cancer Institute at the National Institute of Health, Jacob Schwartz, Ph.D., professor at Department of Chemistry and Biochemistry at the University of Arizona College of Science and researcher at The BIO5 Institute, has created a new drug treatment for a class of cancers. Schwartz’s primary focus is Ewing’s sarcoma, a childhood cancer that is driven by the proteins he and is students are investigating.